Pulmonary Hypertension and Uterine Leiomyomas, Is there a Causal Relationship? Case Series and Pathophysiological Review
Main Article Content
Abstract
Introduction: Uterine leiomyomas are a type of benign neoplasm that frequently appears in women of reproductive age, related to venous thromboembolic disease. This link arises from the effect produced by the compression of fibroids, which generates venous stasis in the pelvic region. However, this seems not to be the only factor that relates it to the subsequent development of pulmonary hypertension, but rather its presence is a trigger for a series of phenomena that influence the pulmonary vasculature and also at a systemic level. Method: Review of a series of cases (six) cared for in our unit, followed by a review on the relationship between leiomyomas and different forms of pulmonary hypertension with a review from the pathophysiology. Result and conclusions: We found bibliographic support in the multiple pathophysiological paths that relate the common vascular mediators, which appear to be the key point in the relationship between these two pathologies.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
-Radin RG, Rosenberg L, Palmer JR, Cozier YC, Kumanyika SK, and Wise LA. Hypertension and risk of uterine leiomyomata in US black women. Human Reproduction 2012;27 1504–1509. Doi: 10.1093/humrep/des046.
-Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG 2017; 124: 1501–1512. Doi: 10.1111/1471-0528.14640
-Luo N, Guan Q, Zheng L, Qu X, Dai H, and Cheng Z. Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation.Translational Research 2014;163: 232–241. Doi: 10.1016/j.trsl.2013.11.008.
-Knowles J, Loizidou M, and Taylor I. Endothelin-1 and angiogenesis in cancer. Current Vascular Pharmacology 2005; 3: 309–314. Doi: 10.2174/157016105774329462.
-Ribatti D, Tamma R. Hematopoietic growth factors and tumor angiogenesis. Cancer Letters 2019; 440–441: 47–53. Doi: 10.1016/j.canlet.2018.10.008.
-Bussolino F, Wang JM, Defilippi P et al. Granulocyte- and granulocyte-macrophage- colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989; 337:471–473. Doi: 10.1038/337471a0.
-Endemann DH, and Schiffrin EL. Endothelial dysfunction. Am J Nephrol 2004;15: 1983–1992.
Doi: 10.1097/01.ASN.0000132474.50966.DA.
-Wallace K, Chatman K, Porter J et al. Endothelin 1 is elevated in plasma and explants from patients having uterine leiomyomas. Reproductive Sciences 2014;21: 1196–1205. Doi: 10.1177/1933719114542018.
- Kirschen GW, AlAshqar A, Miyashita-Ishiwata M, Reschke L, Sabeh M, Borahay MA. Vascular Biology of Uterine Fibroids: Connecting Fibroids and Vascular Disorders. Reproduction 2021; 162(2): R1–R18. Doi: 10.1530/REP-21-0087.
-Saleh L, Verdonk K, Visser W, Van Den Meiracker AH, Danser AH. The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia. Ther Adv Cardiovasc Dis 2016;10 282–293. Doi: 10.1177/1753944715624853
-Chen DC, Liu JY, Wu GJ, Ku CH, Su HY, Chen CH. Serum vascular endothelial growth factor165 levels and uterine fibroid volume. Acta Obstet Gynecol Scand 2005; 84: 317–321.
Doi: 10.1080/j.0001-6349.2005.00621.x.
-Jonca F, Ortega N, Gleizes PE, Bertrand N, Plouet J. Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor. J Biol Chem 1997; 272: 24203–24209. Doi: 10.1074/jbc.272.39.24203